To the adjusting of complement system is a kind of form of therapy of a large amount of pathologic conditions relevant with complement activation.In the strategy of the complement inhibitor for preparing targeting complement activation and disease site, such compositions is disclosed, said composition comprises the complement inhibitor that is connected with complement receptors (CR) 2.Disclosed said composition can be used for the treatment of in the method for pathogenicity disease and inflammatory diseases by regulating complement system.
